Investors Buy Shares of Danaher Corp. (DHR) on Weakness
Traders bought shares of Danaher Corp. (NYSE:DHR) on weakness during trading on Monday. $48.05 million flowed into the stock on the tick-up and $32.08 million flowed out of the stock on the tick-down, for a money net flow of $15.97 million into the stock. Of all equities tracked, Danaher Corp. had the 12th highest net in-flow for the day. Danaher Corp. traded down ($0.25) for the day and closed at $81.19
A number of analysts have commented on the stock. Goldman Sachs Group Inc. assumed coverage on shares of Danaher Corp. in a report on Tuesday, July 5th. They issued a “neutral” rating and a $74.00 price objective for the company. Sanford C. Bernstein upgraded shares of Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price objective for the company in a report on Thursday, June 23rd. JPMorgan Chase & Co. reiterated a “buy” rating and issued a $105.00 price objective on shares of Danaher Corp. in a report on Thursday, June 30th. Citigroup Inc. increased their price objective on shares of Danaher Corp. from $102.00 to $104.00 and gave the company a “neutral” rating in a report on Monday, June 13th. Finally, Royal Bank Of Canada increased their price objective on shares of Danaher Corp. from $96.00 to $99.00 and gave the company a “sector perform” rating in a report on Friday, May 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $95.68.
The stock has a 50 day moving average of $81.13 and a 200-day moving average of $74.97. The stock has a market capitalization of $56.06 billion and a price-to-earnings ratio of 16.15.
Danaher Corp. (NYSE:DHR) last announced its quarterly earnings data on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.03. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.76 billion. During the same period in the previous year, the company posted $1.08 EPS. The business’s quarterly revenue was up 16.6% on a year-over-year basis. Equities analysts anticipate that Danaher Corp. will post $3.56 earnings per share for the current year.
In related news, CFO Daniel L. Comas sold 96,446 shares of the company’s stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the transaction, the chief financial officer now owns 215,716 shares of the company’s stock, valued at $17,447,110.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the company’s stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the transaction, the insider now directly owns 179,054 shares in the company, valued at approximately $14,582,157.76. The disclosure for this sale can be found here.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.